Synchrony is a premier consumer financial services company. The Company delivers a wide range of specialized financing programs, as well as innovative consumer banking products, across key industries including digital, retail, home, auto, travel, health and pet. Synchrony enables its partners to grow sales and loyalty with consumers. It's one of the largest issuers of private label credit cards in the United States; it also offers co-branded products, installment loans and consumer financing products for small- and medium-sized businesses, as well as healthcare providers.

Company profile
Ticker
SYF, SYF+A
Exchange
Website
CEO
Alberto Casellas
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
CareCredit LLC • Loop Commerce, Inc. • Pets Best Insurance Services, LLC • Retail Finance • Retail Finance International Holdings, Inc. • RFS Holding, Inc. • RFS Holding, L.L.C. • Sherman Clay & Co., LLC • Synchrony Financial Canada • Synchrony Financial Canada Company ...
SYF stock data
News
Morgan Stanley Maintains Equal-Weight on Synchrony Finl, Raises Price Target to $32
19 Jul 22
Stephens & Co. Maintains Equal-Weight on Synchrony Finl, Raises Price Target to $35
19 Jul 22
Credit Suisse Maintains Outperform on Synchrony Finl, Raises Price Target to $47
19 Jul 22
Recap: Synchrony Finl Q2 Earnings
18 Jul 22
Synchrony Finl Q2 EPS $1.60 Beats $1.47 Estimate
18 Jul 22
Press releases
Synchrony Announces Quarterly Common Stock Dividend of $0.23 Per Share
21 Jul 22
2022 Disability Equality Index Awards Synchrony Top Score for Sixth Consecutive Year
20 Jul 22
Synchrony Convenes Employees for Three-Day Global Diversity Experience
19 Jul 22
Synchrony Reports Second Quarter 2022 Results
18 Jul 22
"PAY WITH SYNCHRONY" APP LAUNCHES AS FIRST COMBINED PRIVATE LABEL AND BNPL FINANCING SOLUTION AVAILABLE FOR SMALL BUSINESS VIA CLOVER®
14 Jul 22
Analyst ratings and price targets
Current price
Average target
$39.57
Low target
$32.00
High target
$49.00
Morgan Stanley
Maintains
$32.00
Stephens & Co.
Maintains
$35.00
Credit Suisse
Maintains
$47.00
JMP Securities
Maintains
$40.00
Wells Fargo
Downgraded
$32.00
Barclays
Maintains
$49.00
Piper Sandler
Maintains
$42.00
Calendar
21 Jul 22
13 Aug 22
31 Dec 22
Financial summary
Quarter (USD) | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 10.79B | 10.79B | 10.79B | 10.79B | 10.79B | 10.79B |
Cash burn (monthly) | 44.67M | 62.67M | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 65.08M | 91.31M | n/a | n/a | n/a | n/a |
Cash remaining | 10.72B | 10.7B | n/a | n/a | n/a | n/a |
Runway (months of cash) | 240.1 | 170.7 | n/a | n/a | n/a | n/a |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Jul 22 | Carol Juel | Common Stock | Payment of exercise | Dispose F | No | No | 28.59 | 363 | 10.38K | 86,550 |
1 Jul 22 | Bart Schaller | Common Stock | Payment of exercise | Dispose F | No | No | 28.59 | 703 | 20.1K | 68,208 |
30 Jun 22 | Coviello Arthur W JR | Common Stock | Grant | Acquire A | No | No | 27.62 | 1,494 | 41.26K | 36,082 |
30 Jun 22 | Kamila K Chytil | Common Stock | Grant | Acquire A | No | No | 27.62 | 1,494 | 41.26K | 1,494 |
30 Jun 22 | Guthrie Roy A | Common Stock | Grant | Acquire A | No | No | 27.62 | 1,494 | 41.26K | 45,194 |
Institutional ownership, Q1 2022
99.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 685 |
Opened positions | 65 |
Closed positions | 130 |
Increased positions | 245 |
Reduced positions | 279 |
13F shares | Current |
---|---|
Total value | 16.61B |
Total shares | 476.98M |
Total puts | 3.03M |
Total calls | 2.46M |
Total put/call ratio | 1.2 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 63.08M | $2.2B |
Capital World Investors | 49.29M | $1.72B |
BLK Blackrock | 47.85M | $1.67B |
FMR | 30.76M | $1.07B |
STT State Street | 25.17M | $876.09M |
Geode Capital Management | 10.28M | $357.32M |
BAC Bank Of America | 9.99M | $347.73M |
Arrowstreet Capital, Limited Partnership | 9.89M | $344.18M |
GIC Private | 9.46M | $328.22M |
GS Goldman Sachs | 8.12M | $282.79M |
Financial report summary
?Management Discussion
- Below are highlights of our performance for the three and six months ended June 30, 2022 compared to the three and six months ended June 30, 2021, as applicable, except as otherwise noted.
- •Net earnings decreased to $804 million from $1.2 billion and to $1.7 billion from $2.3 billion. The decreases in the three and six months ended June 30, 2022 were primarily driven by increases in provision for credit losses due to reserve releases in the prior year, partially offset by higher net interest income.
- •Loan receivables increased to $82.7 billion at June 30, 2022 compared to $78.4 billion at June 30, 2021, driven by strong purchase volume growth, partially offset by the sale of $3.8 billion of loan receivables in the second quarter of 2022. Excluding the impact of the sale of these portfolios, loan receivables increased 11.5% reflecting strong purchase volume growth of 12.1% and 14.1% for the three and six months ended June 30, 2022, respectively.
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AdventHealth, ago, Cosmetic, Electric, footprint, HVAC, inventory, Kevin, Kymco, Lucid, Marine, Mitsubishi, Rarebreed, Sit, Sleep, solution, Suveto, Suzuki, Sweetwater, Trane, Zone
Removed:
adversary, approval, arbitration, attempting, bankruptcy, Belton, Code, collect, compel, correct, declaratory, denied, denying, discharge, discharged, entered, expire, failing, GE, injunction, injunctive, owing, reconsideration, relief, resulted, reversing, scheduled, show, Southern, staying, vacated, York
Financial reports
Current reports
8-K
Regulation FD Disclosure
18 Jul 22
8-K
Results of Operations and Financial Condition
18 Jul 22
8-K
Other Events
13 Jun 22
8-K
Regulation FD Disclosure
13 Jun 22
8-K
Submission of Matters to a Vote of Security Holders
25 May 22
8-K
Regulation FD Disclosure
13 May 22
8-K
Regulation FD Disclosure
18 Apr 22
8-K
Results of Operations and Financial Condition
18 Apr 22
8-K
Synchrony Names Kamila Chytil to Board of Directors
5 Apr 22
8-K
Entry into a Material Definitive Agreement
4 Apr 22
Registration and prospectus
S-3ASR
Automatic shelf registration
21 Jul 22
424B5
Prospectus supplement for primary offering
10 Jun 22
FWP
Free writing prospectus
8 Jun 22
424B5
Prospectus supplement for primary offering
8 Jun 22
424B5
Prospectus supplement for primary offering
26 Oct 21
FWP
Free writing prospectus
25 Oct 21
424B5
Prospectus supplement for primary offering
25 Oct 21
8-A12B
Registration of securities on exchange
15 Nov 19
424B5
Prospectus supplement for primary offering
7 Nov 19
FWP
Free writing prospectus
6 Nov 19
Proxies
DEFA14A
Additional proxy soliciting materials
6 Apr 21
DEFA14A
Additional proxy soliciting materials
21 Apr 20
DEFA14A
Additional proxy soliciting materials
5 Apr 19
DEFA14A
Additional proxy soliciting materials
26 Apr 18
DEF 14A
Definitive proxy
3 Apr 18
DEFA14A
Additional proxy soliciting materials
3 Apr 18
Other
UPLOAD
Letter from SEC
25 Jun 20
CORRESP
Correspondence with SEC
24 Jun 20
UPLOAD
Letter from SEC
18 Jun 20
CERT
Certification of approval for exchange listing
18 Nov 19
EFFECT
Notice of effectiveness
8 Nov 15
CORRESP
Correspondence with SEC
5 Nov 15
CORRESP
Correspondence with SEC
2 Nov 15
UPLOAD
Letter from SEC
28 Oct 15
CT ORDER
Confidential treatment order
12 Oct 15
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
22 Feb 15
Ownership
SC 13G/A
Synchrony Financial / Capital World Investors ownership change
10 Aug 22
4
Synchrony Financial / Bart Schaller ownership change
5 Jul 22
4
Synchrony Financial / Carol Juel ownership change
5 Jul 22
4
Synchrony Financial / FERNANDO AGUIRRE ownership change
5 Jul 22
4
Synchrony Financial / Paget Leonard Alves ownership change
5 Jul 22
4
Synchrony Financial / JEFFREY G NAYLOR ownership change
5 Jul 22
4
Synchrony Financial / P.W. Parker ownership change
5 Jul 22
4
Synchrony Financial / Laurel Richie ownership change
5 Jul 22
4
Synchrony Financial / Ellen M Zane ownership change
5 Jul 22
4
Synchrony Financial / Will W Graylin ownership change
5 Jul 22
Transcripts
2022 Q2
Earnings call transcript
18 Jul 22
2022 Q1
Earnings call transcript
18 Apr 22
2021 Q4
Earnings call transcript
28 Jan 22
2021 Q3
Earnings call transcript
19 Oct 21
2021 Q2
Earnings call transcript
20 Jul 21
2021 Q1
Earnings call transcript
27 Apr 21
2020 Q4
Earnings call transcript
29 Jan 21
2020 Q3
Earnings call transcript
20 Oct 20
2020 Q2
Earnings call transcript
21 Jul 20
2020 Q1
Earnings call transcript
21 Apr 20
Reddit threads
(8/1) Monday's Pre-Market Stock Movers & News
1 Aug 22
Daily Discussion Thread - July 29th, 2022
29 Jul 22
Daily Discussion Thread - July 28th, 2022
28 Jul 22
Daily Discussion Thread - July 27th, 2022
27 Jul 22
(7/25) Monday's Pre-Market Stock Movers & News
25 Jul 22
(7/25) Monday's Pre-Market Stock Movers & News
25 Jul 22
[Weekly Megathread] Markets and Value Stock Ideas, Week of July 25, 2022
25 Jul 22
(7/21) Thursday's Pre-Market Stock Movers & News
21 Jul 22
(7/20) Wednesday's Pre-Market Stock Movers & News
20 Jul 22
(7/19) Tuesday's Pre-Market Stock Movers & News
19 Jul 22